RecruitingOsteoarthritis Knee Pain
Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain
Eligible age
40+ yrs
Accepts
All genders
Locations
13 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
A Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 for the Treatment of Knee Pain in Patients with Osteoarthritis of the Knee.
Sponsor: Saol Therapeutics Inc
You may qualify if…
- ✓ 1. Male or female patients ≥ 40 years of age
- ✓ 2. Body Mass Index (BMI) limits
- ✓ 3. Chronic knee pain resulting from osteoarthritis
- ✓ 4. Kellgren-Lawrence Grade 2 (mild) or Grade 3 (moderate)
- ✓ 5. Baseline KOOS pain
- ✓ 6. Patients taking baseline analgesics
- ✓ 7. Diagnostic nerve block response
- ✓ 8. Compliance with identified study requirements
You may not qualify if…
- ✕ 1. Non-OA inflammatory arthritis
- ✕ 2. Confounding elements
- ✕ 3. Lower limb amputation.
- ✕ 4. Specified alternate historic treatments
- ✕ 5. Identified underlying physiologic or psychosocial conditions
- ✕ 6. Patient Health Questionnaire
- ✕ 7. Moderate to severe hepatic impairment
- ✕ 8. Moderate to severe renal impairment
Where it's recruiting
California
Roseville · San Diego
Colorado
Greenwood Village
District of Columbia
Washington D.C.
Florida
Coral Gables · Orlando · The Villages · Winter Park
Minnesota
Rochester
North Carolina
Charlotte · Winston-Salem
Oklahoma
Edmond
Oregon
Eugene
Pennsylvania
Altoona · Sewickley
South Carolina
Charleston · Greenville
Texas
Bellaire · Corpus Christi · Tyler
Utah
Salt Lake City
Source: ClinicalTrials.gov · NCT07226258 · last updated 2026-08-25